Literature DB >> 26637867

Suppression of AKT Potentiates Synergistic Cytotoxicity of Apigenin with TRAIL in Anaplastic Thyroid Carcinoma Cells.

Si Hyoung Kim1, Jun Goo Kang1, Chul Sik Kim1, Sung-Hee Ihm1, Moon Gi Choi1, Hyung Joon Yoo1, Seong Jin Lee2.   

Abstract

BACKGROUND: We studied the effect of apigenin in combination with tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on cell survival and the influence of AKT inhibition on the combined effect of apigenin with TRAIL in anaplastic thyroid carcinoma (ATC) cells.
MATERIALS AND METHODS: The human 8505C and CAL62 ATC cell lines were used.
RESULTS: Apigenin in combination with TRAIL, compared to apigenin alone, reduced cell viability and Bcl2 protein levels, elevated the percentage of dead cells, as well as the protein levels of cleaved PARP and phospho-ERK1/2. The protein levels of Bcl-xL, Bax, Bid, total ERK1/2, and total and phospho-AKT were unchanged. Administration of wortmannin further reduced cell viability, and elevated the percentage of dead cells, cytotoxic activity and cleaved PARP protein levels.
CONCLUSION: Apigenin synergizes with TRAIL through regulation of Bcl2 family proteins in inducing cytotoxicity, and suppression of AKT potentiates synergistic cytotoxicity of apigenin with TRAIL in ATC cells. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  AKT; Anaplastic thyroid carcinoma; Bcl2; TRAIL; apigenin

Mesh:

Substances:

Year:  2015        PMID: 26637867

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells.

Authors:  S H Kim; J G Kang; C S Kim; S-H Ihm; M G Choi; H J Yoo; S J Lee
Journal:  J Endocrinol Invest       Date:  2017-11-16       Impact factor: 4.256

2.  Evodiamine in combination with histone deacetylase inhibitors has synergistic cytotoxicity in thyroid carcinoma cells.

Authors:  Si Hyoung Kim; Jun Goo Kang; Chul Sik Kim; Sung-Hee Ihm; Moon Gi Choi; Seong Jin Lee
Journal:  Endocrine       Date:  2019-05-17       Impact factor: 3.633

3.  Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells.

Authors:  Si Hyoung Kim; Jun Goo Kang; Chul Sik Kim; Sung-Hee Ihm; Moon Gi Choi; Hyung Joon Yoo; Seong Jin Lee
Journal:  Endocrine       Date:  2017-12-28       Impact factor: 3.633

Review 4.  Apigenin in cancer therapy: anti-cancer effects and mechanisms of action.

Authors:  Xiaohui Yan; Miao Qi; Pengfei Li; Yihong Zhan; Huanjie Shao
Journal:  Cell Biosci       Date:  2017-10-05       Impact factor: 7.133

5.  Cytotoxic Activity of Propolis Extracts from the Stingless Bee Trigona Sirindhornae Against Primary and Metastatic Head and Neck Cancer Cell Lines

Authors:  Kusumawadee Utispan; Bordin Chitkul; Sittichai Koontongkaew
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01

Review 6.  Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatment.

Authors:  Zeeshan Javed; Haleema Sadia; Muhammad Javed Iqbal; Shazia Shamas; Kausar Malik; Rais Ahmed; Shahid Raza; Monica Butnariu; Natalia Cruz-Martins; Javad Sharifi-Rad
Journal:  Cancer Cell Int       Date:  2021-04-01       Impact factor: 5.722

7.  Exploring the Natural Compounds in Flavonoids for Their Potential Inhibition of Cancer Therapeutic Target MEK1 Using Computational Methods.

Authors:  Wejdan M AlZahrani; Shareefa A AlGhamdi; Torki A Zughaibi; Mohd Rehan
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-03

Review 8.  Anticancer effects of natural phytochemicals in anaplastic thyroid cancer (Review).

Authors:  Yitian Li; Jing Zhang; Huihui Zhou; Zhen Du
Journal:  Oncol Rep       Date:  2022-07-20       Impact factor: 4.136

9.  Apigenin Induced Apoptosis by Downregulating Sulfiredoxin Expression in Cutaneous Squamous Cell Carcinoma.

Authors:  Wenhua Wang; Xin Liu; Zhibao Zhang; Mingzhu Yin; Xiang Chen; Shuang Zhao; Lisha Wu
Journal:  Oxid Med Cell Longev       Date:  2022-08-04       Impact factor: 7.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.